v3.26.3
Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($)
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Total
Balances (in shares) at Dec. 31, 2024 270,175,766      
Balances at Dec. 31, 2024 $ 27,018 $ 134,875,666 $ (142,279,717) $ (7,377,033)
Stock-based compensation expense 0 126,067 0 126,067
Net loss $ 0 0 (5,346,031) (5,346,031)
Issuance of common stock and restricted stock, net of fees (in shares) 49,645,391      
Issuance of common stock and restricted stock, net of fees $ 4,965 42,824,922 0 42,829,887
Exercise of options, net of fees (in shares) 503,935      
Exercise of options, net of fees $ 50 485,353 0 485,403
Balances (in shares) at Mar. 31, 2025 320,325,092      
Balances at Mar. 31, 2025 $ 32,033 178,312,008 (147,625,748) 30,718,293
Issuance of common stock and restricted stock, net of fees $ (4,965) (42,824,922) 0 (42,829,887)
Balances (in shares) at Dec. 31, 2024 270,175,766      
Balances at Dec. 31, 2024 $ 27,018 134,875,666 (142,279,717) (7,377,033)
Net loss       (16,635,440)
Balances (in shares) at Sep. 30, 2025 320,802,502      
Balances at Sep. 30, 2025 $ 32,081 178,840,963 (158,915,157) 19,957,887
Balances (in shares) at Mar. 31, 2025 320,325,092      
Balances at Mar. 31, 2025 $ 32,033 178,312,008 (147,625,748) 30,718,293
Stock-based compensation expense 0 160,728 0 160,728
Net loss $ 0 0 (7,795,322) (7,795,322)
Issuance of common stock and restricted stock, net of fees (in shares) 121,260      
Issuance of common stock and restricted stock, net of fees $ 12 3,728 0 (3,716)
Balances (in shares) at Jun. 30, 2025 320,446,352      
Balances at Jun. 30, 2025 $ 32,045 178,469,008 (155,421,070) 23,079,983
Issuance of common stock and restricted stock, net of fees (12) (3,728) 0 3,716
Stock-based compensation expense 0 191,069 0 191,069
Net loss $ 0 0 (3,494,087) (3,494,087)
Exercise of options, net of fees (in shares) 356,150      
Exercise of options, net of fees $ 36 180,886 0 180,922
Balances (in shares) at Sep. 30, 2025 320,802,502      
Balances at Sep. 30, 2025 $ 32,081 178,840,963 (158,915,157) 19,957,887
Balances (in shares) at Dec. 31, 2025 320,947,028      
Balances at Dec. 31, 2025 $ 32,096 179,089,487 (167,598,279) 11,523,304
Stock-based compensation expense 0 954,062 0 954,062
Net loss $ 0 0 (17,757,011) (17,757,011)
Balances (in shares) at Mar. 31, 2026 320,947,028      
Balances at Mar. 31, 2026 $ 32,096 180,043,549 (185,355,290) (5,279,645)
Balances (in shares) at Dec. 31, 2025 320,947,028      
Balances at Dec. 31, 2025 $ 32,096 179,089,487 (167,598,279) 11,523,304
Net loss       (28,048,400)
Balances (in shares) at Sep. 30, 2026 358,650,622      
Balances at Sep. 30, 2026 $ 35,866 229,395,690 (195,646,679) 33,784,877
Balances (in shares) at Mar. 31, 2026 320,947,028      
Balances at Mar. 31, 2026 $ 32,096 180,043,549 (185,355,290) (5,279,645)
Stock-based compensation expense 0 144,142 0 144,142
Net loss $ 0 0 (7,381,761) (7,381,761)
Issuance of common stock and restricted stock, net of fees (in shares) 32,543,930      
Issuance of common stock and restricted stock, net of fees $ 3,254 41,580,851 0 41,584,105
Balances (in shares) at Jun. 30, 2026 353,490,958      
Balances at Jun. 30, 2026 $ 35,350 221,768,542 (192,737,051) 29,066,841
Issuance of common stock and restricted stock, net of fees (3,254) (41,580,851) 0 (41,584,105)
Stock-based compensation expense 0 1,195,550 0 1,195,550
Net loss $ 0 0 (2,909,628) (2,909,628)
Exercise of options, net of fees (in shares) 5,081,539      
Exercise of options, net of fees $ 508 6,385,392 0 6,385,900
Exercise of warrants, net of fees (in shares) 78,125      
Exercise of warrants, net of fees $ 8 46,206 0 46,214
Balances (in shares) at Sep. 30, 2026 358,650,622      
Balances at Sep. 30, 2026 $ 35,866 $ 229,395,690 $ (195,646,679) $ 33,784,877